Skip to main content

Post-IPO Equity Biotechnology Companies

Explore 483 biotechnology startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
483
Total Funding
$500.4M
Avg Funding
$62.5M
Cities
8

Export 483 Post-IPO Equity Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Spokane, United States
$4.0M
raised

Gridiron BioNutrients is an emerging company in the rapidly-growing CBD hemp-oil industry.

Nov 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Saint Laurent, Canada
$101.2M
raised

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Oct 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oslo, Norway
$32.3M
raised

Ultimovacs is a pharmaceutical company developing novel immunotherapies against cancer.

Oct 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Culver City, United States
$200.0M
raised

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Oct 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Toronto, Canada
$7.9M
raised

PharmaTher Holdings pecializes in the development and commercialization of ketamine-based medicines.

Sep 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 483 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Philadelphia, United States
$30.0M
raised

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

Sep 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Fort Collins, United States
$75.0M
raised

Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.

Jul 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Jul 2021
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 476 to 483 of 483 companies

Ready to Connect with Post-IPO Equity Biotechnology Startups?

Get verified founder emails, funding details, and company data for 483 post-ipo equity biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

483 Biotechnology Post-IPO Equity Startups (November 2026) — Page 20 | VCBacked